Evidence map›Paper›PMID 36451656›Full record

ArticleBrain communications2022

Alterations of the axon initial segment in multiple sclerosis grey matter.

Aysegul Dilsizoglu Senol, Giulia Pinto, Maxime Beau, Vincent Guillemot, Jeffrey L Dupree, Christine Stadelmann, Jonas Ranft, Catherine Lubetzki, Marc Davenne

Open access · goldAbstract read
In one paragraph

Article in Brain communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Aysegul Dilsizoglu SenolSorbonne University, Paris Brain Institute-ICM, Inserm, CNRS, Pitié-Salpêtrière Hospital, Paris, France.
Giulia PintoSorbonne University, Paris Brain Institute-ICM, Inserm, CNRS, Pitié-Salpêtrière Hospital, Paris, France.
Maxime BeauInstitut de Biologie de l'École Normale Supérieure (IBENS), École Normale Supérieure, CNRS, Inserm, PSL Research University, Paris, France.
Vincent GuillemotSorbonne University, Paris Brain Institute-ICM, Inserm, CNRS, Pitié-Salpêtrière Hospital, Paris, France.
Jeffrey L DupreeDepartment of Anatomy and Neurobiology, Virginia Commonwealth University, Richmond, VA, USA.
Christine StadelmannInstitute of Neuropathology, University Medical Center Göttingen, Göttingen 37075, Germany.ORCID https://orcid.org/0000-0003-1766-5458
Jonas RanftInstitut de Biologie de l'École Normale Supérieure (IBENS), École Normale Supérieure, CNRS, Inserm, PSL Research University, Paris, France.
Catherine LubetzkiSorbonne University, Paris Brain Institute-ICM, Inserm, CNRS, Pitié-Salpêtrière Hospital, Paris, France.
Marc DavenneSorbonne University, Paris Brain Institute-ICM, Inserm, CNRS, Pitié-Salpêtrière Hospital, Paris, France.
Centre National de la Recherche Scientifique · FRUniversitätsmedizin Göttingen · DEVirginia Commonwealth University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Grey matter damage has been established as a key contributor to disability progression in multiple sclerosis. Aside from neuronal loss and axonal transections, which predominate in cortical demyelinated lesions, synaptic alterations have been detected in both demyelinated plaques and normal-appearing grey matter, resulting in functional neuronal damage. The axon initial segment is a key element of neuronal function, responsible for action potential initiation and maintenance of neuronal polarity. Despite several reports of profound axon initial segment alterations in different pathological models, among which experimental auto-immune encephalomyelitis, whether the axon initial segment is affected in multiple sclerosis is still unknown. Using immunohistochemistry, we analysed axon initial segments from control and multiple sclerosis tissue, focusing on layer 5/6 pyramidal neurons in the neocortex and Purkinje cells in the cerebellum and performed analysis on the parameters known to control neuronal excitability, i.e. axon initial segment length and position. We found that the axon initial segment length was increased only in pyramidal neurons of inactive demyelinated lesions, compared with normal appearing grey matter tissue. In contrast, in both cell types, the axon initial segment position was altered, with an increased soma-axon initial segment gap, in both active and inactive demyelinated lesions. In addition, using a computational model, we show that this increased gap between soma and axon initial segment might increase neuronal excitability. Taken together, these results show, for the first time, changes of axon initial segments in multiple sclerosis, in active as well as inactive grey matter lesions in both neocortex and cerebellum, which might alter neuronal function.

Indexed as

axon initial segmentcerebellumgrey matter lesionmultiple sclerosisneocortex

Identifiers

PMID36451656
PMCPMC9700164
OpenAlexW4308342512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.